These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 37627216)

  • 21. Targeting the Tumor Microenvironment for Improving Therapeutic Effectiveness in Cancer Immunotherapy: Focusing on Immune Checkpoint Inhibitors and Combination Therapies.
    Chyuan IT; Chu CL; Hsu PN
    Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33801815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Computational principles and practice for decoding immune contexture in the tumor microenvironment.
    Zhang Z; Bao S; Yan C; Hou P; Zhou M; Sun J
    Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32496512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dissecting Immunosuppressive Cell Communication Patterns Reveals JunB Proto-Oncogene (JUNB) Shaping a Non-Inflamed Tumor Microenvironment.
    Chen H; Chen G
    Front Genet; 2022; 13():883583. PubMed ID: 35812726
    [No Abstract]   [Full Text] [Related]  

  • 24. Single-Cell Genomic Characterization Reveals the Cellular Reprogramming of the Gastric Tumor Microenvironment.
    Sathe A; Grimes SM; Lau BT; Chen J; Suarez C; Huang RJ; Poultsides G; Ji HP
    Clin Cancer Res; 2020 Jun; 26(11):2640-2653. PubMed ID: 32060101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Promising immunotherapeutic targets in lung cancer based on single-cell RNA sequencing.
    Xue Q; Peng W; Zhang S; Wei X; Ye L; Wang Z; Xiang X; Zhang P; Zhou Q
    Front Immunol; 2023; 14():1148061. PubMed ID: 37187731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Evasion Mechanisms of Cancer Immunity and Drug Intervention in the Tumor Microenvironment.
    Kim SK; Cho SW
    Front Pharmacol; 2022; 13():868695. PubMed ID: 35685630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unraveling tumor microenvironment of small-cell lung cancer: Implications for immunotherapy.
    Li T; Qiao T
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):117-125. PubMed ID: 36183998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Going with the Flow: Modeling the Tumor Microenvironment Using Microfluidic Technology.
    Xie H; Appelt JW; Jenkins RW
    Cancers (Basel); 2021 Dec; 13(23):. PubMed ID: 34885161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Roles of CD38 and CD157 in the Solid Tumor Microenvironment and Cancer Immunotherapy.
    Wo YJ; Gan ASP; Lim X; Tay ISY; Lim S; Lim JCT; Yeong JPS
    Cells; 2019 Dec; 9(1):. PubMed ID: 31861847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Roles of the CXCL8-CXCR1/2 Axis in the Tumor Microenvironment and Immunotherapy.
    Han ZJ; Li YB; Yang LX; Cheng HJ; Liu X; Chen H
    Molecules; 2021 Dec; 27(1):. PubMed ID: 35011369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Engineering approaches for studying immune-tumor cell interactions and immunotherapy.
    Shelton SE; Nguyen HT; Barbie DA; Kamm RD
    iScience; 2021 Jan; 24(1):101985. PubMed ID: 33490895
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Lou E
    Front Oncol; 2020; 10():559548. PubMed ID: 33324545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunotherapy and tumor microenvironment.
    Tang H; Qiao J; Fu YX
    Cancer Lett; 2016 Jan; 370(1):85-90. PubMed ID: 26477683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NK cells are never alone: crosstalk and communication in tumour microenvironments.
    Zhou Y; Cheng L; Liu L; Li X
    Mol Cancer; 2023 Feb; 22(1):34. PubMed ID: 36797782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor microenvironment (TME)-driven immune suppression in B cell malignancy.
    Nicholas NS; Apollonio B; Ramsay AG
    Biochim Biophys Acta; 2016 Mar; 1863(3):471-482. PubMed ID: 26554850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytokines Orchestrating the Natural Killer-Myeloid Cell Crosstalk in the Tumor Microenvironment: Implications for Natural Killer Cell-Based Cancer Immunotherapy.
    Gaggero S; Witt K; Carlsten M; Mitra S
    Front Immunol; 2020; 11():621225. PubMed ID: 33584718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single-cell transcriptome analysis revealed a suppressive tumor immune microenvironment in EGFR mutant lung adenocarcinoma.
    Yang L; He YT; Dong S; Wei XW; Chen ZH; Zhang B; Chen WD; Yang XR; Wang F; Shang XM; Zhong WZ; Wu YL; Zhou Q
    J Immunother Cancer; 2022 Jan; 10(2):. PubMed ID: 35140113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanoparticles overcome adaptive immune resistance and enhance immunotherapy
    Zhang X; Wang X; Hou L; Xu Z; Liu Y; Wang X
    Front Pharmacol; 2023; 14():1130937. PubMed ID: 37033636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of autophagy fires up the cold tumor microenvironment to improve cancer immunotherapy.
    Jin Z; Sun X; Wang Y; Zhou C; Yang H; Zhou S
    Front Immunol; 2022; 13():1018903. PubMed ID: 36300110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune evasion in esophageal squamous cell cancer: From the perspective of tumor microenvironment.
    Li R; Huang B; Tian H; Sun Z
    Front Oncol; 2022; 12():1096717. PubMed ID: 36698392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.